AVI Calls On Rohto To Prioritise Core Business, Improve Shareholder Engagement

KUALA LUMPUR, April 9 (Bernama) -- Asset Value Investors Limited (AVI) has launched a campaign calling for Rohto Pharmaceutical (Rohto) to refocus its successful core businesses, such as skincare and eye care, and abandon its ongoing investments in the unprofitable regenerative medicine sector.